Neurocrine Biosciences, Inc.
MX ˙ BMV ˙ US64125C1099
SecurityMX:NBIX / Neurocrine Biosciences, Inc.
InstitutionGeode Capital Management, Llc
Latest Disclosed Ownership2,136,672 shares
Latest Disclosed Value $ 280,802,611
Geode Capital Management, Llc reports 3.76% increase in ownership of NBIX / Neurocrine Biosciences, Inc.

On May 15, 2026 - Geode Capital Management, Llc filed a 13F-HR form disclosing ownership of 2,136,672 shares of Neurocrine Biosciences, Inc. (MX:NBIX) valued at $280,802,611 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 9, 2026 disclosing 2,059,282 shares of Neurocrine Biosciences, Inc.. This represents a change in shares of 3.76% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 2,136,672 77,390 3.76 280,803 -3.62 0.0093
2026-02-09 2025-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 2,059,282 34,457 1.70 291,342 2.77 0.0180
2025-11-12 2025-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 2,024,825 65,560 3.35 283,499 15.45 0.0181
2025-08-08 2025-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 1,959,265 -10,489 -0.53 245,565 12.95 0.0172
2025-05-13 2025-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 1,969,754 94,692 5.05 217,413 -14.91 0.0171
2025-02-12 2024-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 1,875,062 15,830 0.85 255,523 19.53 0.0198
2024-11-12 2024-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 1,859,232 39,610 2.18 213,773 -14.53 0.0173
2024-08-09 2024-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 1,819,622 105,908 6.18 250,114 5.98 0.0219
2024-05-13 2024-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 1,713,714 90,590 5.58 236,007 10.52 0.0218
2024-02-13 2023-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 1,623,124 68,494 4.41 213,548 22.25 0.0223
2023-11-13 2023-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 1,554,630 31,222 2.05 174,679 21.79 0.0208
2023-08-11 2023-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 1,523,408 87,671 6.11 143,431 -1.17 0.0169
2023-05-15 2023-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 1,435,737 47,042 3.39 145,127 87,855.76 0.0188
2023-02-13 2022-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 1,388,695 71,001 5.39 166 -99.88 0.0233
2022-11-14 2022-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 1,317,694 37,089 2.90 139,843 12.16 0.0212
2022-08-12 2022-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 1,280,605 -3,434 -0.27 124,687 3.73 0.0183
2022-05-13 2022-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 1,284,039 46,491 3.76 120,209 14.22 0.0150
2022-02-11 2021-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 1,237,548 25,327 2.09 105,246 -9.34 0.0127
2021-11-12 2021-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 1,212,221 9,087 0.76 116,090 -0.71 0.0156
2021-08-13 2021-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 1,203,134 23,626 2.00 116,924 2.05 0.0161
2021-05-12 2021-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 1,179,508 53,898 4.79 114,572 6.32 0.0175
2021-02-12 2020-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 1,125,610 59,008 5.53 107,760 5.16 0.0181
2020-11-13 2020-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 1,066,602 -42,408 -3.82 102,470 -24.20 0.0201
2020-08-13 2020-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 1,109,010 36,376 3.39 135,187 45.74 0.0289
2020-05-14 2020-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 1,072,634 37,404 3.61 92,762 -16.57 0.0242
2020-02-20 2019-12-31 13F/A-1 NEUROCRINE BIOSCIENCES COM 64125C109 1,035,230 52,052 5.29 111,181 25.50 0.0232
2020-02-13 2019-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 1,035,230 52,052 111,181 14,169.0436
2019-11-12 2019-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 983,178 6,854 0.70 88,593 7.48 0.0207
2019-08-14 2019-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 976,324 27,195 2.87 82,431 -1.42 0.0199
2019-05-14 2019-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 949,129 41,837 4.61 83,618 29.06 0.0217
2019-03-06 2018-12-31 13F/A-1 NEUROCRINE BIOSCIENCES COM 64125C109 907,292 36,508 4.19 64,789 -39.48 0.0200
2019-02-13 2018-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 907,292 36,508 64,789
2018-11-13 2018-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 870,784 33,581 4.01 107,062 30.17 0.0302
2018-08-14 2018-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 837,203 51,850 6.60 82,246 26.28 0.0253
2018-05-15 2018-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 785,353 22,518 2.95 65,128 10.04 0.0212
2018-02-13 2017-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 762,835 12,347 1.65 59,188 28.70 0.0201
2017-11-14 2017-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 750,488 34,097 4.76 45,989 39.56 0.0170
2017-08-14 2017-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 716,391 39,068 5.77 32,953 12.36 0.0130
2017-06-21 2017-03-31 13F/A-1 NEUROCRINE BIOSCIENCES INC COM COM 64125C109 677,323 42,752 6.74 29,328 19.43 0.0120
2017-05-12 2017-03-31 13F NEUROCRINE BIOSCIENCES INC COM COM 64125C109 677,323 29,328
2017-02-14 2016-12-31 13F NEUROCRINE BIOSCIENCES INC COM COM 64125C109 634,571 52,232 8.97 24,557 -16.72 0.0114
2016-11-10 2016-09-30 13F NEUROCRINE BIOSCIENCES INC COM COM 64125C109 582,339 28,908 5.22 29,489 17.24 0.0148
2016-08-12 2016-06-30 13F NEUROCRINE BIOSCIENCES INC COM COM 64125C109 553,431 -29,538 -5.07 25,153 9.10 0.0137
2016-05-13 2016-03-31 13F NEUROCRINE BIOSCIENCES INC COM COM 64125C109 582,969 28,169 5.08 23,056 -26.54 0.0122
2016-02-12 2015-12-31 13F NEUROCRINE BIOSCIENCES INC COM COM 64125C109 554,800 19,003 3.55 31,385 47.22 0.0179
2015-11-13 2015-09-30 13F NEUROCRINE BIOSCIENCES INC COM COM 64125C109 535,797 7,610 1.44 21,319 -15.49 0.0129
2015-08-14 2015-06-30 13F NEUROCRINE BIOSCIENCES INC COM COM 64125C109 528,187 33,953 6.87 25,226 28.53 0.0144
2015-05-14 2015-03-31 13F NEUROCRINE BIOSCIENCES INC COM COM 64125C109 494,234 68,026 15.96 19,626 106.13 0.0112
2015-02-12 2014-12-31 13F NEUROCRINE BIOSCIENCES INC COM COM 64125C109 426,208 10,535 2.53 9,521 46.18 0.0057
2014-11-14 2014-09-30 13F NEUROCRINE BIOSCIENCES INC COM COM 64125C109 415,673 1,577 0.38 6,513 5.99 0.0042
2014-08-13 2014-06-30 13F NEUROCRINE BIOSCIENCES INC COM COM 64125C109 414,096 8,367 2.06 6,145 -5.92 0.0040
2014-05-14 2014-03-31 13F NEUROCRINE BIOSCIENCES INC COM COM 64125C109 405,729 93,806 30.07 6,532 124.24 0.0044
2014-02-14 2013-12-31 13F NEUROCRINE BIOSCIENCES INC COM COM 64125C109 311,923 26,234 9.18 2,913 -9.93 0.0020
2013-11-14 2013-09-30 13F NEUROCRINE BIOSCIENCES INC COM COM 64125C109 285,689 35,667 14.27 3,234 -3.32 0.0026
2013-08-14 2013-06-30 13F NEUROCRINE BIOSCIENCES INC COM COM 64125C109 250,022 250,022 3,345 0.0029
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.